Bath & Body Works, Inc. $BBWI Holdings Reduced by Makaira Partners LLC

Key Points

• Makaira Partners LLC has reduced its stake in Bath & Body Works, Inc. by 27.6%, now holding approximately 1.64 million shares valued at about $49.7 million.
• A range of institutional investors have recently adjusted their positions in Bath & Body Works, with notable increases such as Wealth Enhancement Advisory Services, which raised its holdings by 38.9%.
• The company reported quarterly earnings of $0.49 per share, exceeding analysts' expectations, and has announced a quarterly dividend of $0.20 per share to be paid on September 5th.

Makaira Partners LLC lessened its stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 27.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,639,039 shares of the company's stock after selling 623,467 shares during the period. Bath & Body Works makes up approximately 16.7% of Makaira Partners LLC's holdings, making the stock its 2nd largest position. Makaira Partners LLC owned about 0.77% of Bath & Body Works worth $49,696,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of BBWI. SVB Wealth LLC purchased a new position in shares of Bath & Body Works in the 1st quarter worth $35,000. Golden State Wealth Management LLC lifted its holdings in Bath & Body Works by 94.7% in the first quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock valued at $40,000 after acquiring an additional 642 shares during the period. UMB Bank n.a. lifted its holdings in Bath & Body Works by 65.9% in the first quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock valued at $46,000 after acquiring an additional 596 shares during the period. Ancora Advisors LLC purchased a new position in Bath & Body Works in the fourth quarter worth about $67,000. Finally, GKV Capital Management Co. Inc. bought a new stake in shares of Bath & Body Works during the 1st quarter valued at about $69,000. 95.14% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on BBWI shares. The Goldman Sachs Group reduced their price target on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a research report on Friday, May 30th. Telsey Advisory Group restated an "outperform" rating and set a $38.00 target price on shares of Bath & Body Works in a research report on Thursday. Piper Sandler set a $39.00 target price on shares of Bath & Body Works and gave the company an "overweight" rating in a report on Thursday, May 15th. Citigroup dropped their price target on shares of Bath & Body Works from $42.00 to $40.00 and set a "buy" rating on the stock in a research note on Tuesday, August 19th. Finally, Wells Fargo & Company boosted their price objective on shares of Bath & Body Works from $40.00 to $44.00 and gave the company an "overweight" rating in a research report on Wednesday, May 14th. Fourteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $42.53.

Bath & Body Works Stock Down 6.6%

NYSE:BBWI traded down $2.08 during trading hours on Thursday, hitting $29.47. 17,266,529 shares of the stock traded hands, compared to its average volume of 4,970,217. The company has a market cap of $6.24 billion, a price-to-earnings ratio of 7.86, a price-to-earnings-growth ratio of 1.06 and a beta of 1.54. Bath & Body Works, Inc. has a 1 year low of $24.94 and a 1 year high of $41.87. The stock has a 50 day moving average price of $30.61 and a 200 day moving average price of $30.86.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.37. Bath & Body Works had a net margin of 11.10% and a negative return on equity of 47.44%. The firm had revenue of $1.55 billion during the quarter, compared to analysts' expectations of $1.55 billion. During the same period in the prior year, the company posted $0.37 earnings per share. The company's revenue for the quarter was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Equities analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 5th. Shareholders of record on Friday, August 22nd will be issued a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, August 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 2.7%. Bath & Body Works's dividend payout ratio (DPR) is currently 21.33%.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.